A randomized, double-blind, placebo-controlled trial to evaluate the effect of enalapril in patients with clinical diabetic nephropathy (Q67586312)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1442757%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

title

A randomized, double-blind, placebo-controlled trial to evaluate the effect of enalapril in patients with clinical diabetic nephropathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1442757%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

1 reference

placebo-controlled trial

1 reference

1 reference

1 reference

J. H. Bauer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1442757

27 September 2022

G. P. Reams

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1442757

27 September 2022

J. Hewett

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1442757

27 September 2022

D. Klachko

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1442757

27 September 2022

A. Lau

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1442757

27 September 2022

C. Messina

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1442757

27 September 2022

V. Knaus

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1442757

27 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1442757

27 September 2022

publication date

1 November 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1442757%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

15 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1442757%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1442757%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1442757%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

page(s)

443-457

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1442757%20AND%20SRC:MED&resulttype=core&format=json

Microalbuminuria as a predictor of clinical diabetic nephropathy

15 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Diabetic nephropathy: hemodynamic basis and implications for disease management

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

The natural history and epidemiology of diabetic nephropathy. Implications for prevention and control

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Captopril in patients with type II diabetes and renal insufficiency: systemic and renal hemodynamic alterations.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Hormonal and metabolic effects of enalapril treatment in hypertensive subjects with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Hemodynamic, renal, and humoral effects of the calcium entry blocker nicardipine and converting enzyme inhibitor captopril in hypertensive type II diabetic patients with nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Effect of captopril on heavy proteinuria in azotemic diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Limitations of creatinine as a filtration marker in glomerulopathic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Measurement of urinary para-aminohippuric acid in glycosuric diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Random-effects models for longitudinal data

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Nonparametric analysis of covariance for comparing change in randomized studies with baseline values subject to error

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Analysis of covariance in parallel-group clinical trials with pretreatment baselines.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Use of analysis of covariance in clinical trials: a clarification

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Short term effect of captopril on microalbuminuria induced by exercise in normotensive diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Enalapril reduces microalbuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Enalapril reduces albumin excretion in diabetic patients with low levels of microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

Renal protective effect of strict blood pressure control with enalapril therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970256-1

7 January 2021

10.1016/S0272-6386(12)70256-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1442757%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

1 reference